Practice English Speaking&Listening with: Dr. Schaffner: Remdesivir Is A ‘Firm First Step’ For A Covid-19 Treatment | The Last Word | MSNBC
INFECTIOUS DISEASES AT VANLT VANDERBILT AND JOHN HOLMAN IS
VANDERBILT AND JOHN HOLMAN IS WITH US, AND EDITOR AND CHIEF OF
WITH US, AND EDITOR AND CHIEF OF "THE RECOUNT."
"THE RECOUNT." DR. SCHEFFNER.
DR. SCHEFFNER. WHAT IS YOUR IMPRESSION OF DR.
WHAT IS YOUR IMPRESSION OF DR. FAUCI’S LOOK ON REMDESIVIR.
FAUCI’S LOOK ON REMDESIVIR. >> I’M SMILING, LAWRENCE.
>> I’M SMILING, LAWRENCE. WE NEED GOOD NEWS.
WE NEED GOOD NEWS. LONG JOURNEYS BEGIN WITH FIRST
LONG JOURNEYS BEGIN WITH FIRST STEPS BUT THIS WAS A FIRM FIRST
STEPS BUT THIS WAS A FIRM FIRST STEP.
STEP. IT’S VERY EXCITING.
IT’S VERY EXCITING. WE NOW KNOW THAT THERE IS AT
WE NOW KNOW THAT THERE IS AT LEAST ONE DRUG AND MAYBE THERE
LEAST ONE DRUG AND MAYBE THERE ARE OTHERS IN THE RESEARCH
ARE OTHERS IN THE RESEARCH PIPELINE THAT CAN ACT AGAINST
PIPELINE THAT CAN ACT AGAINST THIS VIRAL INFECTION.
THIS VIRAL INFECTION. THE DATA SO FAR THAT HAVE BEEN
THE DATA SO FAR THAT HAVE BEEN RELEASED SHOW AS TONY SAID THAT
RELEASED SHOW AS TONY SAID THAT PEOPLE CAN LEAVE THE HOSPITAL
PEOPLE CAN LEAVE THE HOSPITAL SOONER AND THERE’S A TREND
SOONER AND THERE’S A TREND TOWARD INCREASING SURVIVAL.
TOWARD INCREASING SURVIVAL. THAT’S REALLY VERY EXCITING.
THAT’S REALLY VERY EXCITING. NOW IT’S NOT A MAGIC BULLET.
NOW IT’S NOT A MAGIC BULLET. IT’S NOT A HOME RUN.
IT’S NOT A HOME RUN. THE JOURNEY IS STILL LONG.
THE JOURNEY IS STILL LONG. WE HAVE FURTHER RESEARCH TO GO.
WE HAVE FURTHER RESEARCH TO GO. WE DON’T EVEN KNOW WHICH COVID
WE DON’T EVEN KNOW WHICH COVID INFECTED PATIENTS BENEFIT THE
INFECTED PATIENTS BENEFIT THE MOST.
MOST. VERY SICK PEOPLE OR ONLY
VERY SICK PEOPLE OR ONLY MODERATELY SICK PEOPLE.
MODERATELY SICK PEOPLE. WE’LL WAIT TO SEE AS THE DATA
WE’LL WAIT TO SEE AS THE DATA ARE FURTHER ANALYZED BUT THIS IS
ARE FURTHER ANALYZED BUT THIS IS A NICE FIRST STEP FORWARD.
A NICE FIRST STEP FORWARD. >> WHAT I WAS STRUCK BY IN THE
>> WHAT I WAS STRUCK BY IN THE PRESENTATION IS THE RESEARCH ON
PRESENTATION IS THE RESEARCH ON HIV DRUG TREATMENTS AND HOW YOU
HIV DRUG TREATMENTS AND HOW YOU BEGIN WITH SOMETHING THAT TURNS
BEGIN WITH SOMETHING THAT TURNS OUT TO DO A SMALL PART OF THE
OUT TO DO A SMALL PART OF THE JOB OR MAYBE IT APPEARS TO DO
JOB OR MAYBE IT APPEARS TO DO PART OF THE JOB AND YOU DISCOVER
PART OF THE JOB AND YOU DISCOVER IT’S NOT REALLY DOING THE JOB
IT’S NOT REALLY DOING THE JOB BUT IT IS AT LEAST A RESEARCH
BUT IT IS AT LEAST A RESEARCH BUILDING BLOCK THAT LEADS YOU TO
BUILDING BLOCK THAT LEADS YOU TO ANOTHER BUILDING BLOCK AND KEEP
ANOTHER BUILDING BLOCK AND KEEP ASSEMBLING THEM AND AT SOME
ASSEMBLING THEM AND AT SOME POINT, YOU COULD THROUGH THIS
POINT, YOU COULD THROUGH THIS RESEARCH AND PRODUCT BUILD
RESEARCH AND PRODUCT BUILD SOMETHING THAT REALLY DOES WORK.
SOMETHING THAT REALLY DOES WORK. >> ABSOLUTELY, LAWRENCE.
>> ABSOLUTELY, LAWRENCE. YOU SAID IT VERY WELL.
YOU SAID IT VERY WELL. THIS IS A BEGINNING AND AS DR.
THIS IS A BEGINNING AND AS DR. FAUCI SAID, NOW THEY’RE DOING
FAUCI SAID, NOW THEY’RE DOING TRIALS ADDING OTHER DRUGS.
TRIALS ADDING OTHER DRUGS. THAT’S EXACTLY WHAT WE DID WITH
THAT’S EXACTLY WHAT WE DID WITH HIV, AIDS.
HIV, AIDS. WE ALL REMEMBER THOSE DAYS.
WE ALL REMEMBER THOSE DAYS. WE LIVED THROUGH THEM.
WE LIVED THROUGH THEM. IT LOOKS AS THOUGH NOW PERHAPS
IT LOOKS AS THOUGH NOW PERHAPS WE CAN ASSEMBLE SEVERAL DRUGS
WE CAN ASSEMBLE SEVERAL DRUGS THAT WOULD WORK SEPARATELY AND
THAT WOULD WORK SEPARATELY AND IN COMBINATION THAT GIVE US A
IN COMBINATION THAT GIVE US A MUCH BETTER CHANCE TO INCREASE
MUCH BETTER CHANCE TO INCREASE SURVIVAL AND MAKE PEOPLE BETTER,
SURVIVAL AND MAKE PEOPLE BETTER, FASTER.
FASTER. WE WOULD LOVE TO HAVE THAT
WE WOULD LOVE TO HAVE THAT HAPPEN.
HAPPEN. BUT THEY ALL TAKE TIME.
BUT THEY ALL TAKE TIME. THEY ALL HAVE TO HAVE RIGOROUS
